EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The landscape of long noncoding RNA during cutaneous squamous cell carcinoma progression

Max Bone iD, Daniel Schreyer iD, Mairi Treanor-Taylor iD, Charlotte M Proby iD, Catherine A Harwood iD, Irene M Leigh iD, Peter Bailey iD, Gareth J Inman iD

British Journal of Dermatology · 2025

DOI: 10.1093/bjd/ljaf108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2025. Verfasst von Max Bone und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Cancer Sciences, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Skin Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Skin Foundation, Cancer Research UK, CRUK Scotland Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cutaneous squamous cell carcinoma (cSCC) is a common cancer with a high morbidity rate and poor prognosis for metastatic disease. Disease may progress from premalignant actinic keratosis to invasive and metastatic cSCC, but it is perhaps best characterized as a disease continuum progressing from a differentiated to a progenitor-like state. The critical molecular mediators of this process remain poorly defined. Long noncoding (lnc)RNAs, a relatively unexplored class of RNA molecules > 200 nucleotides long, are likely to have important functional roles in cSCC.

Objectives

To provide a comprehensive landscape of lncRNA expression during the cSCC continuum and to identify potentially functional lncRNA drivers of disease progression.

Methods

We interrogated bulk RNA sequencing (RNAseq) data from 110 patient samples, encompassing healthy sun-exposed skin (n = 26), actinic keratosis (n = 14), primary cSCC (n = 66) and metastases (n = 4), to identify changes in lncRNA expression during disease progression. We developed a bioinformatics pipeline to infer lncRNA function based on co-expression patterns and generated a lncRNA signature score, which we validated in head-and-neck squamous cell carcinoma (HNSC) and pancreatic adenocarcinoma (PAAD). We performed bulk RNAseq on 15 patient-derived cell lines and integrated these data to identify tumour cell-specific lncRNAs and validated our findings in multiple other cSCC gene expression cohorts. Using in vitro knockdown approaches we investigated the functional role of LINC00941.

Results

We found that lncRNA expression alone is sufficient to identify disease states and progression along the cSCC disease continuum. Correlation analysis revealed potentially functionally relevant lncRNAs and the processes they may regulate. We developed a 267 lncRNA signature that correlates with a progenitor-like state and predicts poor prognosis in HNSC and PAAD. Bulk RNAseq of patient-derived cell lines revealed tumour cell-specific lncRNAs, and knockdown of LINC00941 indicated that it is required for cell proliferation and colony formation in vitro.

Conclusions

Our findings provide a comprehensive description of lncRNA transcriptomic changes in cSCC and demonstrate their functional relevance as biomarkers and drivers of disease progression in this and, potentially, other cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingSkin NeoplasmsCarcinoma, Squamous CellHumansDisease ProgressionCell Line, TumorGene Expression Regulation, NeoplasticMaleFemaleKeratosis, ActinicBiomarkers, TumorSkinGene Expression ProfilingAgedSequence Analysis, RNAMiddle Aged

Substanzen

RNA, Long NoncodingBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Cancer Research UK Scotland Institute, Glasgow, Glasgow, UK.
  • Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK.
  • Centre for Cell Biology and Cutaneous Research, Blizzard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Department of Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Botton-Champalimaud Pancreatic Cancer Centre, Lisbon, Portugal.

ORCID-Profile: Max Bone, Daniel Schreyer, Mairi Treanor-Taylor, Charlotte M Proby, Catherine A Harwood, Irene M Leigh, Peter Bailey, Gareth J Inman

Förderung

  • British Skin Foundation
  • Cancer Research UK
  • CRUK Scotland Institute

Zitieren

APA

Bone, M., Schreyer, D., Treanor-Taylor, M., Proby, C. M., Harwood, C. A., Leigh, I. M., Bailey, P., & Inman, G. J. (2025). The landscape of long noncoding RNA during cutaneous squamous cell carcinoma progression. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljaf108

Vancouver

Bone M, Schreyer D, Treanor-Taylor M, Proby CM, Harwood CA, Leigh IM, et al. The landscape of long noncoding RNA during cutaneous squamous cell carcinoma progression. British Journal of Dermatology. 2025. doi:10.1093/bjd/ljaf108

BibTeX
@article{Bone2025,
  author = {Bone, Max and Schreyer, Daniel and Treanor-Taylor, Mairi and Proby, Charlotte M and Harwood, Catherine A and Leigh, Irene M and Bailey, Peter and Inman, Gareth J},
  title = {The landscape of long noncoding RNA during cutaneous squamous cell carcinoma progression},
  journal = {British Journal of Dermatology},
  year = {2025},
  doi = {10.1093/bjd/ljaf108}
}
Kostenlos starten →